Forward Pharma As (FWP) SEC Filing 6-K Foreign Issuer Report for the period ending Friday, July 1, 2022

Forward Pharma As

CIK: 1604924 Ticker: FWP

View differences made from one to another to evaluate Forward Pharma As's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Forward Pharma As.


Assess how Forward Pharma As's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Forward Pharma As's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: FWP
CIK: 1604924
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001171843-22-004782
Submitted to the SEC: Thu Jul 07 2022 4:35:10 PM EST
Accepted by the SEC: Thu Jul 07 2022
Period: Friday, July 1, 2022
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: